Alison Milhous
Vermogen: 5 791 $ op 31-08-2026
Vermogen: 5 791 $ op 31-08-2026
Alison Tjosvold Milhous is currently an Independent Director at VivoSim Labs, Inc. since 2020 and Vice President-Accounting at Erasca, Inc. since 2021.
Formerly, Ms. Milhous was an Audit Partner at Grant Thornton LLP from 2015 to 2019.
Education includes undergraduate studies at California Polytechnic State University (San Luis Obispo).
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VIVOSIM LABS INC 0,77% | 13-08-2026 | 19.899 ( 0,77% ) | 5 791 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| VIVOSIM LABS, INC. | Directeur/Bestuurslid | 15-09-2020 |
| ERASCA, INC. | Comptroller/Controller/Auditor | 01-11-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
Grant Thornton LLP
Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, assurance, tax and advisory services | Corporate Officer/Principal | 01-09-2019 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
VivoSim Labs, Inc.
VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
Grant Thornton LLP
Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, assurance, tax and advisory services | Commercial Services |
California Polytechnic State University (San Luis Obispo)
California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Erasca, Inc.
Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau